This site uses cookies. By using this site you agree to receiving cookies. View Policy.

Belluscura has developed the X-PLOR, a lightweight, portable oxygen delivery device aimed at treating the millions of people globally suffering from chronic lung diseases. The company plans to launch this novel and cost-effective device in the US in 2019, with Europe to follow.

  • Amount raised (£)

    £538,140

  • Company number

    09910883

  • Incorporation date

    10/12/2015

  • Total investors

    302

Details

  • Company number

    09910883

  • Incorporation date

    10/12/2015

  • Company status

    Active

  • Industry type

    Manufacture of consumer electronics

  • Number of current appointments

    3

15 Fetter Lane
London
EC4A 1BW

Crowdcube Funding History

Date Amount No. of Investors
23/04/2019 £538,140 302 View

Key Financials

View all financials
2017 2018
Turnover £285.92k £194.39k
Cash £146.52k £421.35k
Increase in Cash £-867.48k £286.35k

Financial data drawn from last filed accounts don't necessarily reflect current trading activity.

Date Description Type
23/09/2020

Group of companies' accounts made up to 2019-12-31

PDF
30/07/2020

Statement of capital following an allotment of shares on 2020-06-10

PDF
22/07/2020

Resolutions

PDF

People

Name Role Appointed Nationality
DYER, Anthony Stephen Secretary 17/11/2017 British
DYER, Anthony Stephen Director 17/11/2017 British
RAUKER, Robert Director 16/08/2016 American